Top Software Tools for Time-to-Event Analyses in Clinical Trials

Published on 23/12/2025

Best Software Tools for Time-to-Event Analyses in Clinical Trials

Time-to-event (TTE) analysis—commonly used to evaluate survival, disease progression, or treatment failure—is a cornerstone of clinical trials, especially in oncology and chronic disease studies. Robust software tools are essential for implementing survival analysis techniques like Kaplan-Meier estimation, log-rank tests, and Cox proportional hazards models. This guide highlights the most widely used and validated software solutions for survival analysis in pharmaceutical settings.

Whether you are part of a biostatistics team, clinical data group, or regulatory submission unit, choosing the right tool is critical to accuracy, compliance, and effective communication. This tutorial provides a comparative overview of the top platforms, their strengths, and recommended use cases in alignment with CDSCO and USFDA expectations.

Table of Contents

Key Requirements for Survival Analysis Software

Validated and audit-ready per 21 CFR Part 11
Ability to handle censored data
Built-in functions for Kaplan-Meier, log-rank, and Cox regression
Support for graphical outputs (survival curves, forest plots)
Reproducible code or audit trail
Integration with CDISC standards and submission formats

All tools should support compliant workflows and standardized reporting, aligning with Pharma SOP documentation for statistical processes.

1. R and the ‘survival’ Package

Overview: R is an open-source

statistical programming language widely used for clinical trial analysis. The survival package is its cornerstone for TTE analysis.

Key Functions:

survfit(): Kaplan-Meier estimation
coxph(): Cox proportional hazards modeling
survdiff(): Log-rank test
ggsurvplot(): Enhanced visualization using ‘survminer’

R allows complete control over data and graphical output, making it ideal for publications, regulatory appendices, and internal reports. However, validation and version control are required for compliant use in GxP environments.

2. SAS (Statistical Analysis System)

Overview: SAS is a gold-standard commercial tool in the pharmaceutical industry, offering strong validation, audit trails, and regulatory acceptance.

Key Procedures:

PROC LIFETEST: Kaplan-Meier and log-rank test
PROC PHREG: Cox regression
ODS Graphics: Automated KM curve generation

SAS is especially preferred for its integration with CDISC/ADaM datasets and seamless export to submission formats. It supports stability study tracking through macro-driven automation.

3. STATA

Overview: STATA offers a GUI-based and command-line interface with powerful survival analysis capabilities, commonly used in academic and international trials.

Key Functions:

sts graph: Kaplan-Meier plots
stcox: Cox regression
stcurve: Custom survival curve generation
Supports time-varying covariates and stratified models

STATA is ideal for exploratory work and mixed-model survival analysis. Its graphical outputs are high quality and journal-ready.

4. SPSS (Statistical Package for the Social Sciences)

Overview: While less common in regulatory trials, SPSS remains a user-friendly option for early-phase or academic research in survival analysis.

Key Features:

KM survival curves with click-based customization
Cox regression via GUI or syntax
Good for training and teaching environments

SPSS is best suited for smaller trials or institutions that need quick exploratory insights without the complexity of full coding.

5. Python and the ‘lifelines’ Package

Overview: Python is gaining traction in clinical research. The lifelines package enables full survival modeling with elegant syntax and rich visualization.

Highlights:

KaplanMeierFitter(): KM estimation
CoxPHFitter(): Proportional hazards model
Integrated plotting via Matplotlib
Great for automation and reproducibility in modern workflows

Python is useful for algorithm-driven studies and automation, especially when paired with pharma validation tools for script certification.

Comparison Table

Tool	Best For	Validation Status	Visualization Quality
R + survival	Custom analysis and publication graphics	Requires internal validation	High (with ggplot2/survminer)
SAS	Regulatory submission and CDISC reporting	Fully validated (Part 11 compliant)	Moderate to High
STATA	Flexible modeling and academic research	Validated versions available	Very High
SPSS	Intro-level and small trials	Partially validated for teaching use	Moderate
Python + lifelines	Automation and reproducible workflows	Needs external validation	High

Best Practices When Using Survival Tools

Pre-define survival endpoints and censoring rules in SAP
Use validated software per regulatory requirements
Maintain audit trails and version control for scripts
Annotate Kaplan-Meier curves with number-at-risk and medians
Use appropriate tools for Cox assumption testing
Embed outputs into CSR and GMP documentation

Regulatory Submission Considerations

When using any of these tools for clinical trial data analysis:

Ensure output files are traceable and reproducible
Provide scripts or macros in submission datasets (per ICH E3 and E9)
Align outputs with ADaM data structures for survival (e.g., ADSL and ADTTE)
Document software versions and libraries used

Conclusion: Choose the Right Tool for the Right Analysis

Time-to-event analyses demand precision, transparency, and regulatory readiness. From the flexibility of R and Python to the robustness of SAS and STATA, selecting the right survival analysis software is a strategic decision. Each platform brings unique benefits, and your choice should reflect the trial phase, submission needs, and internal validation capacity. By aligning tools with SOPs, statistical plans, and regulatory frameworks, pharma professionals can ensure survival analysis supports both scientific insight and approval success.